000 | 01279 a2200325 4500 | ||
---|---|---|---|
005 | 20250516062316.0 | ||
264 | 0 | _c20120517 | |
008 | 201205s 0 0 eng d | ||
022 | _a2152-2669 | ||
024 | 7 |
_a10.1016/j.clml.2011.02.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCatovsky, Daniel | |
245 | 0 | 0 |
_aChlorambucil--still not bad: a reappraisal. _h[electronic resource] |
260 |
_bClinical lymphoma, myeloma & leukemia _cJun 2011 |
||
300 |
_aS2-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aChlorambucil _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
700 | 1 | _aElse, Monica | |
700 | 1 | _aRichards, Sue | |
773 | 0 |
_tClinical lymphoma, myeloma & leukemia _gvol. 11 Suppl 1 _gp. S2-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clml.2011.02.006 _zAvailable from publisher's website |
999 |
_c21266662 _d21266662 |